Charles Deignan

Track

Insider profile

Currently holds a position at Clearside Biomedical Inc

Performance

Overall performance
2.0
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 8% 8.2% 15.1%
Success rate 30% 68% 82%
Transactions
6 67% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -41%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance

Positions

Position Company Period
Chief Financial Officer Clearside Biomedical Inc Jan. 1, 2012 -
Charles Deignan's trades of Clearside Biomedical Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-01-19 2024-01-19
PrS Proposed sale
19,561
320.68
US$985,329 		19,561 320.68 US$985,329
2024-01-19 2024-01-19
S Sale
70,920 -24.8%
14.62
US$4,527,306 		70,920 -24.8% 14.62 US$4,527,306
2023-01-20 2023-01-19
PlS Planned sale
40,854 -49.7%
424.34
US$870,120 		40,854 -49.7% 424.34 US$870,120
2022-01-20 2022-01-19
PlS Planned sale
8,833 -2.5%
2.09
US$18,461 		8,833 -2.5% 2.09 US$18,461
2021-06-23 2021-06-21
PlS Planned sale
2,938 -0.9%
4.37
US$12,839 		2,938 -0.9% 4.37 US$12,839
2020-06-03 2020-06-01
PlS Planned sale
14,992 -6.4%
1.88
US$28,185 		14,992 -6.4% 1.88 US$28,185
2019-11-13 2019-11-12
B Purchase
7,500 +3.8%
1.14
US$8,550 		7,500 +3.8% 1.14 US$8,550
2019-03-18 2019-03-15
B Purchase
10,000 +15.1%
1.36
US$13,600 		10,000 +15.1% 1.36 US$13,600
2018-03-26 2018-03-23
B Purchase
500 +0.8%
11.79
US$5,895 		500 +0.8% 11.79 US$5,895
2017-08-14 2017-08-14
B Purchase
1,000 +1.6%
7.07
US$7,065 		1,000 +1.6% 7.07 US$7,065
2016-06-07 2016-06-07
S Sale
2 -0.0%
7.00
US$14 		2 -0.0% 7.00 US$14